KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2016 - 2025)

Jazz Pharmaceuticals has reported Asset Utilization Ratio over the past 15 years, most recently at 0.29 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 12.68% to 0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.29 through Dec 2025, down 12.68% year-over-year, with the annual reading at 0.36 for FY2025, 3.7% up from the prior year.
  • Asset Utilization Ratio was 0.29 for Q4 2025 at Jazz Pharmaceuticals, roughly flat from 0.29 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.37 in Q1 2021 and troughed at 0.22 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.33 (2022), against an average of 0.31.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 39.59% in 2021 and later soared 49.0% in 2022.
  • Tracing JAZZ's Asset Utilization Ratio over 5 years: stood at 0.25 in 2021, then surged by 38.09% to 0.34 in 2022, then dropped by 1.61% to 0.34 in 2023, then decreased by 1.18% to 0.34 in 2024, then decreased by 12.68% to 0.29 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.29, 0.29, and 0.28 for Q4 2025, Q3 2025, and Q2 2025 respectively.